Promising myeloma combo trial halted early after only 2 patients
Disease control
Terminated
This early-stage study tested a new oral drug called narazaciclib combined with dexamethasone in people with multiple myeloma that had returned or stopped responding to prior treatments. The goal was to find a safe and effective dose. However, the trial was terminated after enrol…
Phase: PHASE1, PHASE2 • Sponsor: Adriana Rossi • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC